RESPONSE BIOMEDICAL CORP (CIK: 0000806888) EDGAR, Information, Filings... CompaniesBIO.Com

RESPONSE BIOMEDICAL CORP

Mailing address
1781 - 75TH AVENUE W., VANCOUVER, A1, V6P6P2
Phone
604-456-6010
State location
A1
State of incorporation
N/A
Fiscal year end
December 31
SIC
8734 - (CF Office: Office of Trade & Services) SERVICES-TESTING LABORATORIES
Filings
N/A

RESPONSE BIOMEDICAL CORP (CIK: 0000806888) is an American company incorporated in the state of A1. Head office is located at 1781 - 75TH AVENUE W., VANCOUVER, A1, V6P6P2. Work in the industry 8734 - (CF Office: Office of Trade & Services) SERVICES-TESTING LABORATORIES. RESPONSE BIOMEDICAL CORP is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
ISALY SAMUEL D	0001055949	Jun-16-2016	director, 10 percent owner
ORBIMED ADVISORS LLC	0001055951	Jun-16-2016	director, 10 percent owner
Thompson Peter A.	0001357522	Jun-16-2016	director, 10 percent owner
OrbiMed Capital GP III LLC	0001432241	Jun-16-2016	director, 10 percent owner
ORBIMED ASIA GP, LP	0001491520	Jun-16-2016	director, 10 percent owner
OrbiMed Advisors Ltd	0001491569	Jun-16-2016	director, 10 percent owner
Wang Jonathan Jian	0001555242	Jun-16-2016	director, 10 percent owner
Hangzhou Joinstar Medical Instrument & Reagent Co. Ltd.	0001628810	Dec-12-2014	10 percent owner
Zhou Xuyi	0001628822	Dec-12-2014	10 percent owner
Hangzhou Lizhu Medical Instrument & Reagent Co. Ltd.	0001628828	Dec-12-2014	10 percent owner
Xu Wenjie	0001628832	Dec-12-2014	10 percent owner
Fu Liming	0001628833	Dec-12-2014	10 percent owner
Adams William J.	0001556223	Aug-13-2012	officer: CFO & Corporate Secretary
PURVIN JEFFREY L	0001227578	Jul-25-2012	director, officer: Chief Executive Officer
Shannon Timothy Patrick	0001554992	Jul-25-2012	officer: SrVPWorldWideSales&Marketing
Canote Richard	0001545844	Mar-28-2012	officer: Chief Financial Officer
HOLLER ANTHONY F	0000939362	Jan-01-2012	director
SEVERSON CLINTON	0001191152	Jan-01-2012	director
KEEGAN JOSEPH D	0001260556	Jan-01-2012	director
Shuster Lewis	0001471131	Jan-01-2012	director
Tsonis Anastasios	0001538904	Jan-01-2012	officer: Controller
Kinnaird-Steen Barbara	0001538942	Jan-01-2012	officer: Vice President
Massitti Patricia	0001538946	Jan-01-2012	officer: VP - Administration
Wang David	0001539099	Jan-01-2012	director

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by RESPONSE BIOMEDICAL CORP

Filings	Format	Description	Filed/Effective	File/Film Number
15-12G	Document	Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0001437749-16-042871 (34 Act) Size: KB	Dec-02-2016	000-50571 162031063
8-K	Document	Current report filing Acc-no: 0001437749-16-042848 (34 Act) Size: KB	Dec-02-2016	000-50571 162029763
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001437749-16-042846 ( Act) Size: 0 KB	Dec-01-2016
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001437749-16-042844 ( Act) Size: 0 KB	Dec-01-2016
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001437749-16-042842 ( Act) Size: 0 KB	Dec-01-2016
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001437749-16-042841 ( Act) Size: 0 KB	Dec-01-2016
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001437749-16-042840 ( Act) Size: 0 KB	Dec-01-2016
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001437749-16-042839 ( Act) Size: 0 KB	Dec-01-2016
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001437749-16-042830 ( Act) Size: 0 KB	Dec-01-2016
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001437749-16-042828 ( Act) Size: 0 KB	Dec-01-2016
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001437749-16-042826 ( Act) Size: 0 KB	Dec-01-2016
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000947871-16-001737 (34 Act) Size: KB	Dec-01-2016	005-81850 162028931
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001437749-16-042782 (33 Act) Size: KB	Dec-01-2016	333-211494 162026673
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001437749-16-042780 (33 Act) Size: KB	Dec-01-2016	333-189470 162026670
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001437749-16-042778 (33 Act) Size: KB	Dec-01-2016	333-183457 162026665
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001437749-16-042776 (33 Act) Size: KB	Dec-01-2016	333-146900 162026660
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001437749-16-042774 (33 Act) Size: KB	Dec-01-2016	333-126275 162026654
SC 13E3/A	Document	Amendment to Schedule filed to report going private transactions Acc-no: 0001437749-16-042755 (34 Act) Size: KB	Nov-30-2016	005-81850 162025321
8-K	Document	Current report filing Acc-no: 0001437749-16-042183 (34 Act) Size: KB	Nov-15-2016	000-50571 162000090
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001437749-16-042088 (34 Act) Size: KB	Nov-14-2016	000-50571 161995606

Recent 20 filings. View all RESPONSE BIOMEDICAL CORP filings

Overall rating 5.0

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

RESPONSE BIOMEDICAL CORP overview
RESPONSE BIOMEDICAL CORP job
RESPONSE BIOMEDICAL CORP stock
RESPONSE BIOMEDICAL CORP ownership
RESPONSE BIOMEDICAL CORP CEO
RESPONSE BIOMEDICAL CORP documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.